Market Tracker

10/31 11:43am ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.6989
Data as of 11:27am ET
 -0.0019 / -0.27%
Today’s Change
0.65
Today|||52-Week Range
4.00
-24.44%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.70
Today’s open0.70
Day’s range0.69 - 0.71
Volume132,204
Average volume (3 months)326,510
Market cap$42.5M
Dividend yield--
Data as of 11:27am ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-34.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
--Protea Biosciences G...-0.01-1.53%
PBMDPrima BioMed Ltd+0.03+3.04%
BCLIBrainstorm Cell Ther...-0.02-0.41%
CASICASI Pharmaceuticals...+0.09+5.26%
Data as of 11:26am ET, 10/31/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts